Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder
Journal of Addictive Diseases, ISSN: 1055-0887, Vol: 28, Issue: 4, Page: 348-355
2009
- 9Citations
- 306Usage
- 36Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations9
- Citation Indexes9
- CrossRef7
- Usage306
- Downloads293
- Abstract Views13
- Captures36
- Readers36
- 36
Article Description
Antidepressant use in the treatment of bipolar disorder is controversial due the risks of affective switching and cycle acceleration. Studies of non-comorbid samples suggest that the risk can be mitigated with the use of a concomitant mood stabilizer. However, the majority of patients with bipolar disorder will experience a comorbid substance use disorder and little is known about these individuals because they are typically excluded from clinical trials. Patients entering a substance abuse treatment program who had a history of bipolar disorder were interviewed to evaluate antidepressant-induced affective switching with and without concomitant mood stabilizer. Among 41 comorbid participants, the total lifetime antidepressant-induced switch rate was 76%. The switch rate was 56% for patients taking a mood stabilizer and an antidepressant concomitantly. There was no difference between patients with bipolar I and bipolar II disorders.
Bibliographic Details
https://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/539; https://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/1663
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=75149141732&origin=inward; http://dx.doi.org/10.1080/10550880903182994; http://www.ncbi.nlm.nih.gov/pubmed/20155604; https://www.tandfonline.com/doi/full/10.1080/10550880903182994; https://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/539; https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=1538&context=smhs_psych_facpubs; https://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/1663; https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=2662&context=smhs_psych_facpubs
Informa UK Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know